Literature DB >> 24282758

A new cardiac variable identified?

Mark Doyle1.   

Abstract

Women with suspected cardiac syndrome X (CSX) are difficult to diagnosis and treat by conventional means. The women's ischemic syndrome evaluation (WISE) study, which started as an exploration of ischemic heart disease, increasingly focused on CSX, and two papers that represent an outgrowth and extension of this work are featured in this issue. Cardiovascular magnetic resonance imaging (CMRI) can generate a myocardial perfusion reserve index (MPRI) that is shown to be lower in women with CSX compared to normal controls. The MPRI is a ratio of resting to vasodilatation myocardial perfusion uptake and is relatively easy to measure. There is growing evidence that the CMRI measured MPRI provides unique information that should be regarded as a primary indicator of CSX disease severity. The papers describe the low levels of MPRI in a well documented CSX all female patient population. The context of this work and its relationship to other findings is discussed with an emphasis on the unique information that CMRI can provide.

Entities:  

Keywords:  Cardiovascular; cardiac syndrome X (CSX); magnetic resonance imaging (MRI); myocardial perfusion reserve index (MPRI)

Year:  2013        PMID: 24282758      PMCID: PMC3839204          DOI: 10.3978/j.issn.2223-3652.2013.09.02

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  15 in total

1.  Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity.

Authors:  Daniel C Lee; Orlando P Simonetti; Kathleen R Harris; Thomas A Holly; Robert M Judd; Edwin Wu; Francis J Klocke
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690

2.  Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary.

Authors:  Noel Bairey Merz; Robert O Bonow; George Sopko; Robert S Balaban; Richard O Cannon; David Gordon; Mary M Hand; Sharonne N Hayes; Jannet F Lewis; Terry Long; Teri A Manolio; Attilio Maseri; Elizabeth G Nabel; Patrice Desvigne Nickens; Carl J Pepine; Rita F Redberg; Jacques E Rossouw; Harry P Selker; Leslee J Shaw; David D Waters
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

3.  The Yentl syndrome.

Authors:  B Healy
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

4.  Gender differences in the treatment for acute myocardial infarction: bias or biology?

Authors:  R David Anderson; Carl J Pepine
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

5.  Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.

Authors:  Mark Doyle; Nicole Weinberg; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; Anthon Fuisz; William J Rogers; Edward G Walsh; B Delia Johnson; Barry L Sharaf; Carl J Pepine; Sunil Mankad; Steven E Reis; Geetha Rayarao; Diane A Vido; Vera Bittner; Lindsey Tauxe; Marian B Olson; Sheryl F Kelsey; Robert Ww Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-06

6.  Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study.

Authors:  H G Kemp; R A Kronmal; R E Vlietstra; R L Frye
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

7.  Patients with syndrome X have normal transmural myocardial perfusion and oxygenation: a 3-T cardiovascular magnetic resonance imaging study.

Authors:  Theodoros D Karamitsos; Jayanth R Arnold; Tammy J Pegg; Jane M Francis; Jacqueline Birks; Michael Jerosch-Herold; Stefan Neubauer; Joseph B Selvanayagam
Journal:  Circ Cardiovasc Imaging       Date:  2012-02-08       Impact factor: 7.792

8.  Women's early warning symptoms of acute myocardial infarction.

Authors:  Jean C McSweeney; Marisue Cody; Patricia O'Sullivan; Karen Elberson; Debra K Moser; Bonnie J Garvin
Journal:  Circulation       Date:  2003-11-03       Impact factor: 29.690

Review 9.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

10.  Costs and clinical outcomes in individuals without known coronary artery disease undergoing coronary computed tomographic angiography from an analysis of Medicare category III transaction codes.

Authors:  James K Min; Leslee J Shaw; Daniel S Berman; Amanda Gilmore; Ning Kang
Journal:  Am J Cardiol       Date:  2008-06-17       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.